A controversial bill in Tennessee is causing a stir, and it's not just any ordinary legislation. This one has the potential to shake up the pharmacy industry and spark a heated debate.
The Battle for Pharmacy Independence: A Tennessee Story
In Nashville, a bill that aims to prohibit pharmacy benefit managers (PBMs) from owning pharmacies has gained momentum. But here's where it gets controversial: companies like CVS Health are fighting back, threatening to close their doors if this bill becomes law.
The proposed legislation would bar PBMs from having any control over pharmacy licenses in Tennessee. It's a move that supporters argue targets vertical integration, a practice they believe gives large corporations an unfair advantage over independent pharmacies.
Senator Bobby Harshbarger, the bill's sponsor, believes this integration allows big businesses to prioritize their own interests, often at the expense of smaller, local pharmacies. He wants to put a stop to it in Tennessee, but CVS Health isn't taking this lying down.
CVS Health, which owns Aetna and numerous retail pharmacy chains, has warned that if the bill passes, they'll close all 134 of their Tennessee pharmacy locations. That's a bold move, and it's left many wondering about the potential impact on patients and the healthcare system.
This week, CVS Pharmacy representatives were in Nashville, making their case against the bill. Amy Thibault, CVS Health's corporate communications executive director, highlighted the potential closure of their Minute Clinics, which provide essential medical services within their stores.
In a strong statement, CVS Health emphasized the devastating impact the bill could have on pharmacy care access and affordability in Tennessee. They argue it would lead to the closure of vital community pharmacies, reduce home delivery options for those with complex conditions, and even force patients to find new primary care providers.
But lawmakers backing the measure insist it's not about forcing closures. Instead, they propose a divestment or restructuring of PBM-affiliated pharmacies by 2027, with a transition period until the end of 2026.
And this is the part most people miss: a fiscal analysis suggests the financial impact on the state is uncertain. In the short term, there could be higher drug acquisition costs and administrative expenses as pharmacy networks adjust. However, supporters argue the bill could bring much-needed transparency and reduce practices like spread pricing.
In a recent audit, the Tennessee Department of Commerce and Insurance found CVS Caremark guilty of spread pricing, charging certain entities more than they reimbursed pharmacies. This practice, they argue, results in non-compliance with state law and higher medication costs.
Jake Standefer, from Access Pharmacy in Hixson, supports the change, believing it gives patients more choice. He sees it as a way to break up a monopoly and ensure fair competition.
Other healthcare providers have also voiced their concerns, with Dr. Johnetta Blakely, a medical oncologist, stating that PBM practices like prior authorization and step therapy often delay care, especially in oncology where delays can have serious consequences.
As the bill moves forward, the debate intensifies. The potential impact on patients, pharmacies, and the state's healthcare system is a hot topic. With State Sen. Harshbarger's mother, Congresswoman Diana Harshbarger, leading a similar effort on a national level, the eyes of the industry are on Tennessee.
What do you think? Is this bill a necessary step towards a fairer pharmacy industry, or will it cause more harm than good? We'd love to hear your thoughts in the comments!
